115 related articles for article (PubMed ID: 32011453)
1. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
2. [Current WHO classification (2022) of neuroendocrine neoplasms].
Buchstab O; Knösel T
Radiologie (Heidelb); 2024 Apr; ():. PubMed ID: 38622292
[TBL] [Abstract][Full Text] [Related]
3. Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center.
Calissendorff J; Bjellerup-Calissendorff F; Bränström R; Juhlin CC; Falhammar H
Front Endocrinol (Lausanne); 2021; 12():657698. PubMed ID: 33927695
[TBL] [Abstract][Full Text] [Related]
4. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
Chauhan A; Chan K; Halfdanarson TR; Bellizzi AM; Rindi G; O'Toole D; Ge PS; Jain D; Dasari A; Anaya DA; Bergsland E; Mittra E; Wei AC; Hope TA; Kendi AT; Thomas SM; Flem S; Brierley J; Asare EA; Washington K; Shi C
CA Cancer J Clin; 2024 Apr; ():. PubMed ID: 38685134
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
Centonze G; Maisonneuve P; Prinzi N; Pusceddu S; Albarello L; Pisa E; Barberis M; Vanoli A; Spaggiari P; Bossi P; Cattaneo L; Sabella G; Solcia E; La Rosa S; Grillo F; Tagliabue G; Scarpa A; Papotti M; Volante M; Mangogna A; Del Gobbo A; Ferrero S; Rolli L; Roca E; Bercich L; Benvenuti M; Messerini L; Inzani F; Pruneri G; Busico A; Perrone F; Tamborini E; Pellegrinelli A; Kankava K; Berruti A; Pastorino U; Fazio N; Sessa F; Capella C; Rindi G; Milione M
Neuroendocrinology; 2023; 113(4):457-469. PubMed ID: 36417840
[TBL] [Abstract][Full Text] [Related]
6. Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: A morphologic study.
Sigel CS; Krauss Silva VW; Reid MD; Chhieng D; Basturk O; Sigel KM; Daniel TD; Klimstra DS; Tang LH
Cancer Cytopathol; 2018 May; 126(5):326-335. PubMed ID: 29451738
[TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
Basturk O; Tang L; Hruban RH; Adsay V; Yang Z; Krasinskas AM; Vakiani E; La Rosa S; Jang KT; Frankel WL; Liu X; Zhang L; Giordano TJ; Bellizzi AM; Chen JH; Shi C; Allen P; Reidy DL; Wolfgang CL; Saka B; Rezaee N; Deshpande V; Klimstra DS
Am J Surg Pathol; 2014 Apr; 38(4):437-47. PubMed ID: 24503751
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Carcinomas with Atypical Proliferation Index and Clinical Behavior: A Systematic Review.
Feola T; Centello R; Sesti F; Puliani G; Verrico M; Di Vito V; Di Gioia C; Bagni O; Lenzi A; Isidori AM; Giannetta E; Faggiano A
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809007
[TBL] [Abstract][Full Text] [Related]
9. The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study.
Gao S; Pu N; Liu L; Li C; Xu X; Wang X; Lou W
J Cancer; 2018; 9(9):1698-1706. PubMed ID: 29760809
[No Abstract] [Full Text] [Related]
10. Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms.
Angerilli V; Sabella G; Simbolo M; Lagano V; Centonze G; Gentili M; Mangogna A; Coppa J; Munari G; Businello G; Borga C; Schiavi F; Pusceddu S; Leporati R; Oldani S; Fassan M; Milione M
Br J Cancer; 2024 May; ():. PubMed ID: 38729995
[TBL] [Abstract][Full Text] [Related]
11. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract][Full Text] [Related]
12. Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
Marchese U; Gaillard M; Pellat A; Tzedakis S; Abou Ali E; Dohan A; Barat M; Soyer P; Fuks D; Coriat R
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053593
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer.
Janczewski LM; Browner AE; Cotler JH; Nelson H; Kakar S; Carr NJ; Hanna NN; Holowatyj AN; Goldberg RM; Washington MK; Asare EA; Overman MJ;
CA Cancer J Clin; 2023; 73(6):590-596. PubMed ID: 37358310
[TBL] [Abstract][Full Text] [Related]
14. A well differentiated neuroendocrine tumor of the jejunum with peritoneal carcinomatosis: A case report.
Antoniadou F; Korkolis D; Koufopoulos N; Manatakis D; Sakellariou S
Mol Clin Oncol; 2018 Dec; 9(6):651-655. PubMed ID: 30546896
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms.
Borghesani M; Reni A; Lauricella E; Rossi A; Moscarda V; Trevisani E; Torresan I; Al-Toubah T; Filoni E; Luchini C; De Robertis R; Landoni L; Scarpa A; Porta C; Milella M; Strosberg J; Cives M; Cingarlini S
J Natl Compr Canc Netw; 2024 May; ():1-8. PubMed ID: 38744314
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a modified staging system with 8th edition AJCC criteria in a North American cohort of pT2/pT3 HPV-negative penile squamous cell carcinoma.
Tekin B; Sali AP; Menon S; Cheville JC; Smith CY; Jenkins SM; Dasari S; Enninga EAL; Norgan AP; Cubilla AL; Whaley RD; Hernandez LH; Jimenez RE; Garcia JJ; Thompson RH; Leibovich BC; Karnes RJ; Boorjian SA; Pagliaro LC; Erickson LA; Guo R; Gupta S
Hum Pathol; 2024 May; 148():81-86. PubMed ID: 38782101
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival and prognostic indicators in small (Pongprasobchai S; Pannala R; Smyrk TC; Bamlet W; Pitchumoni S; Ougolkov A; de Andrade M; Petersen GM; Chari ST
Pancreatology; 2008; 8(6):587-92. PubMed ID: 18849640
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy in Neuroendocrine Tumors.
Das S; Al-Toubah T; Strosberg J
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638356
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Prognostic Factors for Recurrence of Resected Well-Differentiated Pancreatic Neuroendocrine Tumors.
Li Y; Fan G; Yu F; Tian C; Tan H
Neuroendocrinology; 2021; 111(12):1231-1237. PubMed ID: 33370727
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
